ADAMIS PHARMACEUTICALS CORP (ADMP)
US00547W3079 - Common Stock
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -25.25M | -26.48M | -45.83M | -49.39M | -29.31M | |||
| Depreciation Amortization | 970.00K | 1.48M | 1.44M | 3.61M | 2.94M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | 3.86M | -1.34M | -10.80M | 5.13M | -620.00K | |||
| Interest Paid | N/A | 0.00 | 0.00 | 140.00K | 110.00K | |||
| Taxes Paid | N/A | 0.00 | 0.00 | 10.00K | 10.00K | |||
| Other non cash items | 7.25M | 430.00K | 17.41M | 19.76M | 7.09M | |||
| OPERATING CASH FLOW | -13.17M | -25.91M | -37.79M | -20.90M | -19.89M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -300.00K | -680.00K | -1.22M | -950.00K | -2.87M | |||
| Other Investing Activity | 2.21M | 4.16M | 1.51M | N/A | N/A | |||
| INVESTING CASH FLOW | 1.91M | 3.48M | 280.00K | -950.00K | -2.87M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 1.77M | 3.10M | -500.00K | |||
| Stock Issued/Repurchased | 3.29M | 290.00K | 57.60M | 18.23M | 12.79M | |||
| Other Financing Activity | -280.00K | 0.00 | -5.43M | -1.44M | N/A | |||
| FINANCING CASH FLOW | 3.02M | 290.00K | 53.94M | 19.89M | 12.29M | |||
| CHANGE IN CASH | -8.24M | -22.14M | 16.43M | -1.96M | -10.47M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -13.17M | -25.91M | -37.79M | -20.90M | -19.89M | |||
| Capital Expenditure | -300.00K | -680.00K | -1.22M | -950.00K | -2.87M | |||
| FREE CASH FLOW | -13.47M | -26.59M | -39.01M | -21.85M | -22.76M | |||
All data in USD